Literature DB >> 30041845

Science in Focus: Biological Optimisation of Radiotherapy Fraction Size in an Era of Immune Oncology.

A Wilkins1, A Melcher1, N Somaiah2.   

Abstract

Year:  2018        PMID: 30041845     DOI: 10.1016/j.clon.2018.07.001

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  1 in total

1.  TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells.

Authors:  Selvakumar Anbalagan; Cecilia Ström; Jessica A Downs; Penny A Jeggo; David McBay; Anna Wilkins; Kai Rothkamm; Kevin J Harrington; John R Yarnold; Navita Somaiah
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.